Live feed
Filing
SC 13G/A
SC 13G/A0001654954-19-003213·Caribou Biosciences, Inc.
Schedule 13G ownership disclosure
Intellia Therapeutics Inc
Security class unavailable · CUSIP: 45826J105
Event date: 2019-02-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001654954-19-003213
- Form type
- SC 13G/A
- Filer
- Caribou Biosciences, Inc.
- CIK
- CIK 1619856
- Filed
- Mar 25, 2019
- Reporting period
- Feb 22, 2019
- Description
- Schedule 13G beneficial ownership